S Duttagupta

1.3k total citations
32 papers, 1.0k citations indexed

About

S Duttagupta is a scholar working on Economics and Econometrics, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, S Duttagupta has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 7 papers in Psychiatry and Mental health and 6 papers in Infectious Diseases. Recurrent topics in S Duttagupta's work include Antimicrobial Resistance in Staphylococcus (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Sexual function and dysfunction studies (5 papers). S Duttagupta is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Sexual function and dysfunction studies (5 papers). S Duttagupta collaborates with scholars based in United States, United Kingdom and India. S Duttagupta's co-authors include Stanley E. Althof, Joseph C. Cappelleri, A. Shpilsky, Howard Fillit, Richard L. Siegel, Robert Futterman, Vera Mastey, Jim Z. Li, John A. Weigelt and Kamal M.F. Itani and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Neurology.

In The Last Decade

S Duttagupta

32 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Duttagupta United States 12 515 219 194 164 159 32 1.0k
Kasem S. Akhras United States 22 285 0.6× 71 0.3× 81 0.4× 144 0.9× 220 1.4× 39 1.2k
Michael Johnsrud United States 18 385 0.7× 164 0.7× 82 0.4× 57 0.3× 155 1.0× 40 1.2k
Nasir Wabe Australia 17 87 0.2× 59 0.3× 129 0.7× 142 0.9× 227 1.4× 83 974
Rochelle Henderson United States 17 189 0.4× 89 0.4× 47 0.2× 54 0.3× 96 0.6× 51 841
Reginald P. Sequeira Bahrain 17 236 0.5× 38 0.2× 84 0.4× 39 0.2× 112 0.7× 65 1.2k
Carla Truyers Belgium 15 113 0.2× 36 0.2× 47 0.2× 79 0.5× 163 1.0× 41 930
Esther‐Lee Marcus Israel 16 106 0.2× 99 0.5× 12 0.1× 30 0.2× 141 0.9× 52 980
Lan Jiang United States 18 41 0.1× 42 0.2× 79 0.4× 49 0.3× 271 1.7× 73 876
Julie H. Ishida United States 15 59 0.1× 58 0.3× 37 0.2× 55 0.3× 293 1.8× 24 836
Andrea DiMartini United States 15 98 0.2× 79 0.4× 52 0.3× 22 0.1× 331 2.1× 27 942

Countries citing papers authored by S Duttagupta

Since Specialization
Citations

This map shows the geographic impact of S Duttagupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Duttagupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Duttagupta more than expected).

Fields of papers citing papers by S Duttagupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Duttagupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Duttagupta. The network helps show where S Duttagupta may publish in the future.

Co-authorship network of co-authors of S Duttagupta

This figure shows the co-authorship network connecting the top 25 collaborators of S Duttagupta. A scholar is included among the top collaborators of S Duttagupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Duttagupta. S Duttagupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duttagupta, S, et al.. (2018). Five Years of Risk Sharing Agreements in South Korea: Perils & Pitfalls. Value in Health. 21. S57–S57. 1 indexed citations
2.
Duttagupta, S, et al.. (2015). Economic Sanctions And Market Access for Pharmaceuticals: Case Studies With Russia, Cuba And Iran. Value in Health. 18(7). A569–A569. 4 indexed citations
3.
Duttagupta, S, et al.. (2015). Regulatory Approval for Oncology Products In Brazil: A Comparison Between The Fda And Anvisa Approval Timelines. Value in Health. 18(7). A826–A826. 4 indexed citations
4.
Jiang, Yong, et al.. (2015). Evolution & Influence of HTA in Emerging Markets. Value in Health. 18(7). A557–A557. 2 indexed citations
5.
Cock, E De, Wolfgang A. Krueger, Thomas Baker, et al.. (2009). Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany. Infection. 37(2). 123–132. 33 indexed citations
6.
Cock, E De, et al.. (2009). Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France. Médecine et Maladies Infectieuses. 39(5). 330–340. 17 indexed citations
7.
Schürmann, Dirk, Sonja Sorensen, E De Cock, S Duttagupta, & Ansgar Resch. (2008). Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany. The European Journal of Health Economics. 10(1). 65–79. 24 indexed citations
8.
9.
10.
Itani, Kamal M.F., John A. Weigelt, Jim Z. Li, & S Duttagupta. (2005). Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents. 26(6). 442–448. 93 indexed citations
11.
Nurnberg, H. George & S Duttagupta. (2004). Economic Analysis of Sildenafil Citrate (Viagra??) Add-on to Treat Erectile Dysfunction Associated With Selective Serotonin Reuptake Inhibitor Use. American Journal of Therapeutics. 11(1). 9–12. 18 indexed citations
12.
Cappelleri, Joseph C., et al.. (2004). Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. International Journal of Impotence Research. 16(1). 30–38. 180 indexed citations
13.
14.
15.
Althof, Stanley E., Joseph C. Cappelleri, A. Shpilsky, et al.. (2003). Treatment responsiveness of the Self-Esteem And Relationship questionnaire in erectile dysfunction. Urology. 61(5). 888–892. 96 indexed citations
16.
Futterman, Robert, et al.. (2002). Alzheimer’s disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 58(1). 62–70. 154 indexed citations
17.
Rice, Dorothy P., Howard Fillit, Wendy Max, et al.. (2001). Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.. PubMed. 7(8). 809–18. 96 indexed citations
18.
Provenzano, George, S Duttagupta, Tom McRae, et al.. (2001). PPN13: DELAYS IN NURSING HOME PLACEMENT FOR PATIENTS WITH ALZHEIMER'S DISEASE ASSOCIATED WITH TREATMENT WITH DONEPEZIL MAY HAVE HEALTH CARE COST-SAVING IMPLICATIONS. Value in Health. 4(2). 158–158. 3 indexed citations
19.
Sörensen, Silvia, et al.. (2000). PMDM3: PROJECTING ECONOMIC RESULTS OF A EUROPEAN TRIAL TO THE UNITED STATES: ISSUES AND METHODS. Value in Health. 3(5). 374–374. 1 indexed citations
20.
Acharya, Subrat Kumar, Srinivasan Dasarathy, S Sushma, et al.. (1996). Fulminant Hepatitis in A Tropical Population: Clinical Course, Cause, and Early Predictors of Outcome. Hepatology. 23(6). 1448–1455. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kasem S. Akhras Breakdown of academic impact, for papers by Michael Johnsrud Breakdown of academic impact, for papers by Nasir Wabe Breakdown of academic impact, for papers by Rochelle Henderson Breakdown of academic impact, for papers by Reginald P. Sequeira Breakdown of academic impact, for papers by Carla Truyers Breakdown of academic impact, for papers by Esther‐Lee Marcus Breakdown of academic impact, for papers by Lan Jiang Breakdown of academic impact, for papers by Julie H. Ishida Breakdown of academic impact, for papers by Andrea DiMartini
Rankless by CCL
2026